Jade Biosciences, Inc. (JBIO)
Healthcare
Biotechnology
19.80 $
-1.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Jade Biosciences, Inc. (JBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16 | -15 | -24 | -20 | 37 | -11 | -19 | -37 | -22 | -34 | -24 | -116 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | 0.0 | 1.2 | 2.4 | 3.9 | 4.3 | 9.4 | 7.4 | 25 | |
| 1.5 | 3.3 | -4.0 | 1.1 | 11 | -6.6 | 1.6 | 4.2 | -1.1 | -11 | 9.3 | 2.0 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | |
| -13 | 5.6 | 8.8 | 18 | -27 | 13 | – | -13 | -149 | -98 | -8.5 | -268 | |
| – | – | – | – | 95 | 0.0 | – | – | – | 0.0 | – | – | |
| 0.0 | 0.5 | 0.5 | 24 | 70 | 0.6 | -0.7 | 191 | 0.0 | 170 | -0.8 | 360 | |
| -29 | -8.7 | -14 | 22 | 0.0 | 2.6 | -19 | 177 | -171 | 38 | -33 | 11 | |
| -16 | -15 | -24 | -20 | 37 | -11 | -19 | -37 | -22 | -34 | -24 | -117 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.